Answers are grounded in this paper and cite their sources.
Abstract Aim: to estimate the prevalence of sickle cell disease among children and adolescents in the pediatric department of the Sylvanus Olympio University Hospital in 2022. Methods: in this cross-sectional study, all children and adolescents attending the study site were proposed to participate and included if: i) aged between 18 months and 19 years, ii) present in pediatric consultations or hospitalizations and iii) provided assent or parental informed consent. A 4-5 ml blood sample was collected for hemoglobin electrophoresis on a cellulose acetate plate at alkaline pH. Sickle cell disease was defined as having either SS, SC, SF or Sß hemoglobin phenotype. Results: A total of 317 children and adolescents aged 8 years (IQR: 4-12) in median were enrolled. Only in 7.3% of cases did both parents know their hemoglobin status. 68 children/adolescents had hemoglobin S (21.5%), 19 had sickle cell disease (6.0%). Approximately 15.6% of children and adolescents had sickle cell trait AS. Conclusion: This study revealed a high SCD prevalence in an a priori naïve children/adolescents’ population. We stress that policy makers should consider continued sensitization, genetic counseling and neonatal screening as prevention strategies in Togo.
No takes yet. Share an insight, caveat, or question.
Konu et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: